|
||||||||||||||||||||||||||||||||||||||||||||
Claris Lifesciences Consolidated Q1FY16 PAT Rises 31% | ||||||||||||||||||||||||||||||||||||||||||||
New Delhi, Delhi, India Claris Lifesciences Ltd. (CU) today announced its Un-Audited Financial Results for the quarter ended 30th June 2015 at its board meeting held at its registered office in Ahmedabad.
Management Representation of the Financial of the Speciality Injectable Business:
(Values in Rupees Mn)
Key financial highlights of the Specialty Injectable Business:
Region wise Net Sales (Values in Rupees Mn)
|
||||||||||||||||||||||||||||||||||||||||||||
|
|||||
| |||||